Banijay revenue rises to $4.7 billion as production revenue falls


The group’s first results since its All3Media combination show production revenue fell 3% on a comparable basis, even as acquisitions lifted overall growth.
Banijay’s overall revenue rose 33.9% to $4.7 billion in the first nine months of 2026 compared with 2025, while comparable production revenue at its entertainment division fell. The results are the group’s first since its combination with All3Media closed in July.
The group’s reported increase includes the effects of All3Media and its purchase of betting company Tipico, which closed in April. It is therefore not a measure of television production growth. On a pro-forma basis, which adjusts the comparison for the acquisitions, overall revenue rose 6.6%.
Adjusted EBITDA, a measure of earnings before interest, taxes, depreciation, amortization and company adjustments, rose 37.3% to $901 million, or 3% on a pro-forma basis, Variety said.
Production revenue at Banijay Entertainment, the London-based content division into which All3Media merged, fell 3% pro forma to $1.81 billion. That comparison includes All3Media’s contributions in both 2025 and 2026.
Banijay attributed the decline to the expected timing of program deliveries and a difficult comparison with 2025, when deliveries included “The Buccaneers” and “House of Guinness.”
Distribution revenue fell 5%, while Live revenue rose nearly 46%, supported by work at the Olympic Winter Games and . Live growth helped lift the content division’s overall revenue slightly.
Banijay Entertainment CEO Marco Bassetti said the All3Media combination increased the division’s creative scale, strengthened its English-language output and expanded its digital and distribution capabilities. He said the business remained focused on growth in its core activities and in live, digital and sport.
The measures impose asset freezes and director disqualifications, while separate UK bans on settlement-goods imports and property advertising remain in development.
3 min

The company says the financing will develop its drug-design engine and medicine pipeline and build infrastructure as it advances candidates toward human trials.
2 min

AFP values the proposed takeover at approximately €2.05 billion (about $2.3 billion). The deal needs regulatory approval, including Italy’s clearance for strategic assets, before Iceye can combine satellite operations with rocket production.
3 min